The company is selling contract development and manufacturing organization sites in Tennessee, Maryland, and the UK, as well as a cell solutions site in California.
Of about $600 billion in domestic investments announced in 2025, only $60 billion worth of estimated capital expenditures have specific amounts and locations, finds CBRE.
